Two of the probiotic strains from Lallemand Health Solutions have been approved for two Canadian health claims, paving the way for the strains to be marketed as helping babies develop similar small intestine flora to breastfed infants.
These claims for Bifidobacteria infantis Rosell-33 and Bifidobacteria bifidum Rosell-71 include:
- Helps maintain infant-like bacteria (for formula-fed infants
- Helps balance bacteria that formula feeds on like breastfed babies
Search
At the heart of this health claim are two studies. The first is a randomized, double-blind, placebo-controlled study, where B. infant Rosell-33 was considered safe and well tolerated in 221 healthy infants aged 3 to 12 months.
A post-hoc analysis, based on a sample of infants from the 2017 Manzano study, demonstrated B. infant Rosell-33 can maintain a child’s microbiome profile rich in lactose-digesting bacteria such as Bifidobacteria, regardless of any influencing factors such as diet, birth position, etc.
On the other hand, the placebo group showed a significant increase in common components of a healthy adult gut microbiome, and a decrease in bifidobacteria. In addition, the anti-inflammatory IL-10/IL-12 ratio increased during the eight-week period of drug administration, while the placebo group switched to a more pro-inflammatory state.
“Science and carefully done work over the past years evaluating the safety and beneficial effect of these strains on children’s microflora continues to receive official recognition. This is a major step in demonstrating that our probiotics can contribute to supporting normal gut and immune maturation in early life, “said Solange Henoud, Vice President, Regulation and Compliance at Lallemand Health Solutions.
Strong differentiation feature
Both strains can be formulated into adapted galenic forms such as sachets, sticks and drops or into a raw powder to be added directly into infant formula.
“The industry is showing a strong interest in developing the most nutritious baby formula with exclusive ingredients that meet all the requirements of this specific target market. Given the limited number of recognized strains suitable for infant formula, probiotics can be a powerful distinguishing feature and open the door to the probiotic category for babies,”Indians said.
Henoud added that since both Bifidobacteria infantis Rosell-33 and Bifidobacteria bifidum Rosell-71 were previously identified as GRAS, it is possible to add them as a direct probiotic in infant formula or pour the probiotic powder directly into the infant bottle.
parental awareness
Parents are increasingly understanding the role of microbes in early life to promote gut and immune maturation in time. This awareness of the important role of the gut microbiome goes beyond the gut,”Henoud told NutraIngredients-USA.
The UNICEF “The Importance of Early Moments” report finds that parents are increasingly aware of the importance of the first 1,000 days of life and how they can help build a child’s future, from brain development to immunity, or even happiness.
And according to the 2021 FMCG Guru Early Life Nutrition Survey, more than 42% of parents reported that they aim to get probiotics for their children. This puts probiotics behind protein, but ahead of omega-3s in the supplement space.
Comments
Post a Comment